MARATTO

article · Journal of Pharmacy

Qualitative and Quantitative Phytochemical Profiling of Azadirachta indica Leaves and Their Potential Therapeutic Implications

Abstract

Background: Neem (Azadirachta indica) is widely recognized in traditional medicine for its diverse therapeutic properties. This study investigated the qualitative and quantitative phytochemical composition of neem leaves to provide a scientific basis for its pharmacological potential. Methods: Fresh leaves were collected from Sagamu, Nigeria, identified at the Department of Pharmacology, Olabisi Onabanjo University, and subjected to standard extraction and phytochemical screening techniques. Results: Qualitative analysis revealed the presence of alkaloids, flavonoids, saponins, terpenoids, steroids, polyphenols, and tannins. Quantitative assessment showed flavonoids (13.8 ± 0.17%) and terpenoids (13.13 ± 0.50%) as the predominant constituents, followed by alkaloids (10.67 ± 0.46%) and saponins (2.43 ± 0.32%). The high concentration of flavonoids and terpenoids supports neem’s potential antioxidant and anti-inflammatory activities, while alkaloids, saponins, and tannins may contribute to its antimicrobial, anticancer, and immune-modulatory properties. Conclusion: A. indica leaves are a valuable source of bioactive compounds with significant therapeutic promise, justifying their continued use in traditional medicine and their exploration in modern drug development

Research topics

  • Insect Pest Control Strategies
  • Hibiscus Plant Research Studies
  • Diverse Scientific Research Studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.31436/jop.v6i1.437

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.